FDA Issues Safety Alert on Intestinomicina, Drug Product Marketed as Treatment for Infectious Diarrhea

Silver Spring, Maryland–(ENEWSPF)–September 18, 2012.  The U.S. Food and Drug Administration is warning consumers not to use Intestinomicina, a drug product manufactured in El Salvador and marketed as a treatment for infectious diarrhea and acute gastrointestinal infections. Consumers who have purchased this product should immediately stop taking it and consult with a health care provider.